Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Takeda Pharmaceutical Company Limited has made organizational and reporting line changes in line with Christophe Weber's assumption as Takeda's chief operating officer (COO) as of April 1, 2014, which the company had previously announced....

Amgen has appointed David Piacquad to the new position of senior vice-president, business development. Piacquad will report directly to Robert A. Bradway, chairman and chief executive officer and will be responsible for business development across...

With an investment of more than EUR 500 million ($695 million) at its sites in Wuppertal and Leverkusen, Germany, Bayer will establish additional capacities for the manufacturing of the recombinant factor VIII (rFVIII) hemophilia products that are...

AstraZeneca has agreed to sell its Alderley Park site in Cheshire, United Kingdom (UK) to Manchester Science Parks, a Greater Manchester-based public-private partnership and science park operator. The sale is part of AstraZeneca's...

Almac is expanding its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. Almac is strengthening its Asia Pacific offerings by establishing a new...

Ranbaxy Inc. has initiated a nationwide voluntary Class II recall of atorvastatin calcium tablets, 10 mg, 90-count tablets per bottle, prescription only, based on a product complaint was received by a pharmacist who discovered an...

Caraco Pharmaceutical Laboratories, Ltd. issued a Class II recall of the diabetes drug metformin HCl extended-release  (ER) tablets, USP, 500 mg, prescription only, 500-count bottles due to the presence of foreign tablet based on a...

Takeda Pharmaceutical Company Limited has submitted a new drug application  to the Japanese Ministry of Health, Labor and Welfare for trelagliptin succinate, a treatment for Type 2 diabetes. Trelagliptin succinate, discovered by Takeda...

Teva Pharmaceutical Industries Ltd. has launched the generic equivalent to Xeloda® (capecitabine) tablets, 150 mg and 500 mg, in the United States. Xeloda® is marketed by Genentech in the United States. Teva was the first to receive approval on...

GlaxoSmithKline plc announced  that following the voluntary open offer undertaken by its subsidiary, GlaxoSmithKline Pte Ltd, GSK has successfully increased its stake in its publicly listed pharmaceuticals subsidiary in India (GlaxoSmithKline...